World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
25703
World Ranking
17933
National Ranking
8947

Overview

Myron J. Tong is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on the field of Medicine, with a strong emphasis on Epidemiology and Hepatology. Additional subfields include Molecular Biology, Pathology and Forensic Medicine, and Radiology, Nuclear Medicine and Imaging.

The main topics covered in their work include:

  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Disease and Transplantation
  • Monoclonal and Polyclonal Antibodies Research

Myron J. Tong has published papers in several venues. Frequent publication outlets are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Hepatology
  • Clinical Liver Disease
  • Evidence-based Complementary and Alternative Medicine
  • Hepatoma Research

Recent papers include:

  • "Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines" (2020), Clinical Liver Disease
  • "Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma" (2020), Scientific Reports
  • "Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial" (2022), Evidence-based Complementary and Alternative Medicine
  • "Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes" (2021), Hepatoma Research
  • "Cohort study of familial viral hepatitis and risks of paediatric cancers" (2021), International Journal of Epidemiology

The scientist collaborates frequently with a group of co-authors, including:

  • Paul Y. Kwo
  • Ruipeng Lei
  • Lucia A. Rodriguez
  • Nicholas C. Wu
  • Calvin Q. Pan

Best Publications

  • Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

    Patrick Marcellin;Ting Tsung Chang;Seng Gee Lim;Myron J. Tong

  • Clinical Outcomes after Transfusion-Associated Hepatitis C

    Myron J. Tong;Neveen S. El-Farra;Andrew R. Reikes;Ruth L. Co

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.

    Howard A. Liebman;Barbara C. Furie;Myron J. Tong;Rita A. Blanchard

  • Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection

    Marc Bourlière;Stuart C. Gordon;Steven L. Flamm;Curtis L. Cooper

  • A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

    Ching-Lung Lai;Nancy Leung;Eng-Kiong Teo;Myron Tong

  • Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China

    F.-S. Yeh;M.C. Yu;C.-C. Mo;S. Luo

  • Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

    John P. Duffy;Andrew Vardanian;Elizabeth Benjamin;Melissa Watson

  • Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

    Patrick Marcellin;Ting-Tsung Chang;Seng G Lee Lim;William Sievert

  • Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.

    David S. K. Lu;Nam C. Yu;Steven S. Raman;Piyaporn Limanond

  • Acetaminophen hepatotoxicity and acute liver failure.

    Linda J. Chun;Myron J. Tong;Ronald W. Busuttil;Jonathan R. Hiatt

  • Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

    David S. K. Lu;Nam C. Yu;Steven S. Raman;Charles Lassman

  • The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States.

    Ke-Qin Hu;Myron J. Tong

  • Racial differences in responses to therapy with interferon in chronic hepatitis C

    K. Rajender Reddy;Jay H. Hoofnagle;Myron J. Tong;William M. Lee

  • Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology

    J G McHutchison;L M Blatt;M de Medina;J R Craig

  • Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission.

    Cladd E. Stevens;Patricia E. Taylor;Myron J. Tong;Pearl T. Toy

  • Recurrence of Hepatocellular Carcinoma Following Liver Transplantation: A Review of Preoperative and Postoperative Prognostic Indicators

    Michael A. Zimmerman;R. Mark Ghobrial;Myron J. Tong;Jonathan R. Hiatt

  • An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus.

    Calvin Q. Pan;Zhong–Ping Duan;Kalyan R. Bhamidimarri;Huai–Bin Zou

  • Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization

    Cladd E. Stevens;Pearl T. Toy;Myron J. Tong;Patricia E. Taylor

  • Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.

    Myron J. Tong;Shih-Chien Sun;Berton T. Schaeffer;Nai-Kwei Chang

Frequent Co-Authors

Sammy Saab
Sammy Saab University of California, Los Angeles
Ronald W. Busuttil
Ronald W. Busuttil University of California, Los Angeles
Girish N. Vyas
Girish N. Vyas University of California, San Francisco
Douglas G. Farmer
Douglas G. Farmer University of California, Los Angeles
Shou-Dong Lee
Shou-Dong Lee Taipei Veterans General Hospital
Seng Gee Lim
Seng Gee Lim National University of Singapore
Jonathan R. Hiatt
Jonathan R. Hiatt University of California, Los Angeles
Robert G. Gish
Robert G. Gish University of Nevada Reno
Kris V. Kowdley
Kris V. Kowdley Washington State University
James W. Mosley
James W. Mosley University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online pathways can help you build a rewarding career in health and medicine. Nursing professionals may consider an rn to np bridge program to progress from registered nurse to nurse practitioner. This bridge allows for advanced clinical roles and greater autonomy, often with flexible study options.

For those interested in promoting wellness and healthy living, pursuing a nutritionist online degree can open doors to careers in dietetics, health education, and public health policy. These programs often combine foundational science with practical application, preparing graduates for versatile roles.

Students with a passion for healthcare administration should check out cahme accredited mha online programs. Accredited degrees ensure industry standards are met and support roles in hospital management, policy, and more.

Lastly, busy nurses seeking advancement may benefit from rn to bsn programs with no clinicals. These online degrees help RNs gain deeper knowledge and credentials without the need for additional clinical placements.

Best Scientists Citing Myron J. Tong

Trending Scientists